External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home WCN 2025
Roche and Genentech at

WCN 2025

February 06 - February 09
New Delhi, India
theisn.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
08:45 AM
Duration 30mins Auditorium Brahmkamal Hall
Results from the REGENCY trial assessing efficacy and safety of obinutuzumab in active lupus nephritis
Rovin BH, Furie RA, Garg JP, Santiago MB, Aroca-Martinez G, Zuta Santillan AE, Raghu H, Hassan I, Yoo B, Martins E, Sehgal H, Omachi TA, Schindler T, Pendergraft III WF, Malvar A
Nephrology | Lupus nephritis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.